课题基金 / 基金详情

2011 Gordon Research Conference on Tuberculosis Drug Development

2011 Gordon Research Conference on Tuberculosis Drug Development
2011年戈登结核病药物开发研究会议
批准号:
8125495
负责人:
DAVID R SHERMAN
金额:
$0.8万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-06-01 至 2011-10-31

项目摘要

项目成果

DAVID R SHERMAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This application seeks partial support for the 2011 Gordon Research Conference (GRC) on Tuberculosis (TB) Drug Development to be held in Il Ciocco, Italy from July 3rd - 8th. This biennial event is the most important global conference bringing together researchers from both academia and industry to focus on this problem. Treatment of TB remains a continuing challenge particularly with the increasing problem of drug resistance. New treatments could dramatically improve the results of therapy of both drug-sensitive and drug-resistant disease and compounds with new modes-of-action are being actively sought for this reason. TB drug discovery is an extremely vigorous area of research and is increasingly attracting investigators with diverse backgrounds, including microbiology, chemistry, pharmacology, medicine and clinical research. The 2011 GRC on TB Drug Development will provide an opportunity for new investigators to understand the challenges in the field and for experienced researchers to discuss the latest findings at a particularly critical juncture. PUBLIC HEALTH RELEVANCE: Tuberculosis remains one of the leading causes of death in the world and rates of disease continue to climb. New treatments for tuberculosis could cure this disease and limit its spread. Here we request funding for the major biennial scientific meeting in this area, the 2011 Gordon Research Conference on Tuberculosis Drug Development.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Drug tolerance, bacterial heterogeneity and adverse TB treatment outcomes
A multifactorial pipeline to dissect combinatorial drug efficacy in Tuberculosis
  • 批准号:
    10117593
  • 项目类别:
  • 资助金额:
    $73.08万
  • 财政年份:
    2021
  • 负责人:
    DAVID R SHERMAN
  • 依托单位:
Drug tolerance, bacterial heterogeneity and adverse TB treatment outcomes
  • 批准号:
    10493290
  • 项目类别:
  • 资助金额:
    $14.37万
  • 财政年份:
    2021
  • 负责人:
    DAVID R SHERMAN
  • 依托单位:
A multifactorial pipeline to dissect combinatorial drug efficacy in Tuberculosis
  • 批准号:
    10669196
  • 项目类别:
  • 资助金额:
    $72.12万
  • 财政年份:
    2021
  • 负责人:
    DAVID R SHERMAN
  • 依托单位:
海外基金